Global Tissue-Based Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Tissue-Based Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Tissue-Based Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Immunohistochemistry (IHC)
  • 1.4.3 In Situ Hybridization (ISH)
  • 1.4.4 Digital Pathology and Workflow Management
  • 1.4.5 Special Staining
• 1.5 Market by Application
  • 1.5.1 Global Tissue-Based Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Research Laboratories
  • 1.5.4 Pharmaceutical Companies
  • 1.5.5 Contract Research Organizations
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Tissue-Based Diagnostics Market Perspective (2015-2026)
• 2.2 Global Tissue-Based Diagnostics Growth Trends by Regions
  • 2.2.1 Tissue-Based Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Tissue-Based Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Tissue-Based Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Tissue-Based Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Tissue-Based Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Tissue-Based Diagnostics Players by Market Size
  • 3.1.1 Global Top Tissue-Based Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Tissue-Based Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Tissue-Based Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Tissue-Based Diagnostics Market Concentration Ratio
  • 3.2.1 Global Tissue-Based Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Tissue-Based Diagnostics Revenue in 2019
• 3.3 Tissue-Based Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Tissue-Based Diagnostics Product Solution and Service
• 3.5 Date of Enter into Tissue-Based Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Tissue-Based Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Tissue-Based Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Tissue-Based Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Tissue-Based Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Tissue-Based Diagnostics Market Size (2015-2020)
• 6.2 Tissue-Based Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Tissue-Based Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Tissue-Based Diagnostics Market Size (2015-2020)
• 7.2 Tissue-Based Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Tissue-Based Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Tissue-Based Diagnostics Market Size (2015-2020)
• 8.2 Tissue-Based Diagnostics Key Players in China (2019-2020)
• 8.3 China Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 8.4 China Tissue-Based Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Tissue-Based Diagnostics Market Size (2015-2020)
• 9.2 Tissue-Based Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Tissue-Based Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Tissue-Based Diagnostics Market Size (2015-2020)
• 10.2 Tissue-Based Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Tissue-Based Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Tissue-Based Diagnostics Market Size (2015-2020)
• 11.2 Tissue-Based Diagnostics Key Players in India (2019-2020)
• 11.3 India Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 11.4 India Tissue-Based Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Tissue-Based Diagnostics Market Size (2015-2020)
• 12.2 Tissue-Based Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Tissue-Based Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Tissue-Based Diagnostics Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Roche
  • 13.1.1 Roche Company Details
  • 13.1.2 Roche Business Overview
  • 13.1.3 Roche Tissue-Based Diagnostics Introduction
  • 13.1.4 Roche Revenue in Tissue-Based Diagnostics Business (2015-2020))
  • 13.1.5 Roche Recent Development
• 13.2 Danaher
  • 13.2.1 Danaher Company Details
  • 13.2.2 Danaher Business Overview
  • 13.2.3 Danaher Tissue-Based Diagnostics Introduction
  • 13.2.4 Danaher Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.2.5 Danaher Recent Development
• 13.3 Thermo Fisher Scientific
  • 13.3.1 Thermo Fisher Scientific Company Details
  • 13.3.2 Thermo Fisher Scientific Business Overview
  • 13.3.3 Thermo Fisher Scientific Tissue-Based Diagnostics Introduction
  • 13.3.4 Thermo Fisher Scientific Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.3.5 Thermo Fisher Scientific Recent Development
• 13.4 Abbott
  • 13.4.1 Abbott Company Details
  • 13.4.2 Abbott Business Overview
  • 13.4.3 Abbott Tissue-Based Diagnostics Introduction
  • 13.4.4 Abbott Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.4.5 Abbott Recent Development
• 13.5 Agilent Technologies
  • 13.5.1 Agilent Technologies Company Details
  • 13.5.2 Agilent Technologies Business Overview
  • 13.5.3 Agilent Technologies Tissue-Based Diagnostics Introduction
  • 13.5.4 Agilent Technologies Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.5.5 Agilent Technologies Recent Development
• 13.6 ABCAM
  • 13.6.1 ABCAM Company Details
  • 13.6.2 ABCAM Business Overview
  • 13.6.3 ABCAM Tissue-Based Diagnostics Introduction
  • 13.6.4 ABCAM Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.6.5 ABCAM Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Tissue-Based Diagnostics Introduction
  • 13.7.4 Merck Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 BD
  • 13.8.1 BD Company Details
  • 13.8.2 BD Business Overview
  • 13.8.3 BD Tissue-Based Diagnostics Introduction
  • 13.8.4 BD Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.8.5 BD Recent Development
• 13.9 Hologic
  • 13.9.1 Hologic Company Details
  • 13.9.2 Hologic Business Overview
  • 13.9.3 Hologic Tissue-Based Diagnostics Introduction
  • 13.9.4 Hologic Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.9.5 Hologic Recent Development
• 13.10 Bio Rad
  • 13.10.1 Bio Rad Company Details
  • 13.10.2 Bio Rad Business Overview
  • 13.10.3 Bio Rad Tissue-Based Diagnostics Introduction
  • 13.10.4 Bio Rad Revenue in Tissue-Based Diagnostics Business (2015-2020)
  • 13.10.5 Bio Rad Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer